Get started
ASTRAZENECA PHARMAASTRAZENECA PHARMAASTRAZENECA PHARMA

ASTRAZENECA PHARMA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ASTRAZEN chart


Full chart

ASTRAZEN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪200.99 B‬ INR
Dividend yield (indicated)
0.30%
Price to earnings Ratio (TTM)
207.20
Basic EPS (TTM)
38.80 INR
Net income (FY)
‪1.62 B‬ INR
Revenue (FY)
‪12.96 B‬ INR
Shares float
‪4.88 M‬
Beta (1Y)
1.02

Employees


Employees (FY)
940
Change (1Y)
−7 −0.74%
Revenue / Employee (1Y)
‪13.78 M‬ INR
Net income / Employee (1Y)
‪1.72 M‬ INR

About ASTRAZENECA PHARMA


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
astrazeneca.in
Headquarters
Bangalore
Founded
1979
ISIN
INE203A01020
FIGI
BBG000CNNLY6
AstraZeneca Pharma India Ltd. is engaged in the manufacture, distribution, and marketing of pharmaceutical products and clinical trial services. It focuses in the areas of cardiovascular and metabolic disease, cancer and respiratory, inflammatory, and autoimmune disease. The company was founded on July 11, 1979 and is headquartered in Bangalore, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ASTRAZEN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ASTRAZEN.

Frequently Asked Questions


The current price of ASTRAZEN is 7,837.50 INR — it has decreased by −1.02% in the past 24 hours. Watch ASTRAZENECA PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange ASTRAZENECA PHARMA stocks are traded under the ticker ASTRAZEN.
ASTRAZEN stock has fallen by −2.86% compared to the previous week, the month change is a −6.69% fall, over the last year ASTRAZENECA PHARMA has showed a 42.27% increase.
ASTRAZEN reached its all-time high on Apr 24, 2025 with the price of 9,211.00 INR, and its all-time low was 29.70 INR and was reached on Jul 30, 1998. View more price dynamics on ASTRAZEN chart.
See other stocks reaching their highest and lowest prices.
ASTRAZEN stock is 3.27% volatile and has beta coefficient of 1.02. Track ASTRAZENECA PHARMA stock price on the chart and check out the list of the most volatile stocks — is ASTRAZENECA PHARMA there?
Today ASTRAZENECA PHARMA has the market capitalization of ‪198.69 B‬, it has decreased by −0.04% over the last week.
Yes, you can track ASTRAZENECA PHARMA financials in yearly and quarterly reports right on TradingView.
ASTRAZENECA PHARMA is going to release the next earnings report on May 30, 2025. Keep track of upcoming events with our Earnings Calendar.
ASTRAZEN net income for the last quarter is ‪308.50 M‬ INR, while the quarter before that showed ‪384.30 M‬ INR of net income which accounts for −19.72% change. Track more ASTRAZENECA PHARMA financial stats to get the full picture.
Yes, ASTRAZEN dividends are paid annually. The last dividend per share was 24.00 INR. As of today, Dividend Yield (TTM)% is 0.30%. Tracking ASTRAZENECA PHARMA dividends might help you take more informed decisions.
ASTRAZENECA PHARMA dividend yield was 0.45% in 2023, and payout ratio reached 37.15%. The year before the numbers were 0.49% and 40.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 16, 2025, the company has 940 employees. See our rating of the largest employees — is ASTRAZENECA PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA PHARMA EBITDA is ‪2.17 B‬ INR, and current EBITDA margin is 14.41%. See more stats in ASTRAZENECA PHARMA financial statements.
Like other stocks, ASTRAZEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA PHARMA technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA PHARMA stock shows the buy signal. See more of ASTRAZENECA PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.